Home / Business and Economy / Aurobindo Pharma Arm Incorporates Avogent Lifesciences in India

Aurobindo Pharma Arm Incorporates Avogent Lifesciences in India

2 Sep

Summary

Apitoria Pharma, a subsidiary, formed Avogent Lifesciences.
Avogent will focus on manufacturing and marketing operations.
An initial investment of Rs 5 crore was made in the new entity.

Aurobindo Pharma announced on Tuesday the incorporation of Avogent Lifesciences Private Limited. This new entity is a wholly-owned subsidiary established in India by Apitoria Pharma Private Limited, Aurobindo's own subsidiary. Avogent Lifesciences, incorporated on August 31, 2026, is set to operate within the pharmaceuticals sector.

The primary objective of Avogent Lifesciences is to undertake manufacturing and marketing operations. These activities will span both the Indian market and international territories, directly supporting Aurobindo Pharma's core business focus. Apitoria Pharma has made a 100% cash subscription to Avogent's share capital, amounting to an initial Rs 5 crore.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.